Lexaria Updates Business Development
KELOWNA, BC / ACCESS Newswire / July 6, 2026 / Lexaria Bioscience Corp. NASDAQ:LEXX (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to have experienced many positive meetings with potential pharmaceutical partners and collaborators at the 2026 BIO Internation…